Video Experimental Relacionado
Updated: Jul 15, 2026
08:07
Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
Hay una fuerte asociación entre el síndrome autoinmune de la insulina y el HLA-DR4
Y Uchigata1, S Kuwata, K Tokunaga
1Diabetes Center, Tokyo Women's Medical College, Japan.
Lancet (London, England)
|February 15, 1992
Resumen
El síndrome autoinmune de insulina está relacionado con marcadores genéticos específicos. Este hallazgo sugiere una fuerte predisposición genética en el desarrollo de esta condición, que afecta a la regulación de la insulina.
Área de la Ciencia:
- Inmunología Inmunología.
- Genética La genética.
- Endocrinología Endocrinología.
Sus antecedentes:
- El síndrome autoinmune de la insulina (IAS) se caracteriza por hipoglucemia, altos niveles de insulina y autoanticuerpos contra la insulina.
- El IAS ocurre sin el uso de insulina exógena, lo que indica un origen autoinmune.
Objetivo del estudio:
- Para investigar los factores genéticos asociados con el síndrome autoinmune de insulina.
- Para identificar alelos específicos del antígeno leucocitario humano (HLA) y secuencias de genes vinculados a IAS.
Principales métodos:
- Se realizó la tipificación de HLA en 27 pacientes con IAS y 51 controles sanos.
- Se analizaron las secuencias de nucleótidos de los genes DRB1, DQA1 y DQB1 en pacientes y controles.
Principales resultados:
- Todos los pacientes con IAS poseían el tipo de HLA DR4, significativamente más alto que los controles (OR 72.1).
- Se encontró una combinación alélica específica (Cw4, Bw62, DR4) en el 70% de los pacientes.
- Todos los pacientes compartían alelos DRB1*0406, DQA1*0301 y DQB1*0302 (OR 281), a diferencia de los controles.
Conclusiones:
- El desarrollo del síndrome autoinmune de insulina está fuertemente asociado con predisposiciones genéticas específicas.
- Los alelos HLA, en particular DRB1*0406, DQA1*0301 y DQB1*0302, juegan un papel importante en la susceptibilidad al IAS.
Más Videos Relacionados
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
09:32Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis
Published on: October 15, 2021
Videos de Conceptos Relacionados
01:27Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
01:26Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:26Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...